MannKind | Biaya Penjualan



Cost Of Sales Perubahan Tanggal
Adma Biologics USD 54.22M 5.96M 2024-12
Dynavax Technologies USD 27.54M 14.13M 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Halozyme Therapeutics USD 48.4M 6.35M 2025-03
Insmed USD 21.28M 4.87M 2025-03
MacroGenics USD 5.49M 3.62M 2024-12
MannKind USD 17.02M 588K 2025-03
Merck USD 2.76B 944M 2025-03
Novo Nordisk DKK 11.31B 1.03B 2024-09
Pfizer USD 2.59B 3.06B 2025-03
Sanofi EUR 2.89B 618M 2025-03
Xencor 10.71M 4.56M 2024-09



MannKind Biaya Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - May 2025.